Nasdaq First North-listed Qlucore, a leading provider of software for data analysis and precision diagnostics, today announced that it has entered into a reseller agreement with BioTuring, a pioneering bioinformatics software company based in San Diego, USA. Through this collaboration, Qlucore will distribute BioTuring’s software solutions across Europe. BioTuring is a bioinformatics company pioneering computational […]

Collaboration embeds evidence-grounded agentic AI into scientific workflows across Syneos Health, accelerating research while strengthening scientific rigor, consistency, and sponsor value LONDON — Causaly, the agentic AI platform purpose-built for life sciences research and development, today announced a strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization. The collaboration will help establish a […]

Introducing a new AI approach for accelerated biomarker discovery, demonstrated through Alzheimer’s disease biomarker modeling validated in an independent cohort Basel, Switzerland — Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new AI agent in Genedata Profiler®, its enterprise platform for integrating and analyzing data across […]

BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN). This multi-year collaboration agreement will advance the development and commercialization of two companion diagnostic programs, bringing SOPHiA GENETICS’s decentralized clinical trial assays and companion […]

New offerings deliver a full biochemome as a $200-per-sample full-service readout or a $25-per-sample subscription/enterprise license to run on a laboratory’s own instruments SOMERVILLE, Mass. — PyxisLabs™, Matterworks, Inc.’s AI Native Laboratory for scalable biochemical omics and predictive biology, today announces two commercial offerings: biochemical analysis services and enterprise subscription licenses for quantitative, untargeted biochemical […]

Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]

Lucid Genomics provides in-kind access to its genomic analysis platform for laboratories participating in global undiagnosed disease genomics program. By providing our platform in-kind, we hope to help reduce barriers to genomic diagnostics and support Genetic Alliance’s efforts to expand equitable access for patients with rare diseases.” — Uira Souto Melo, Co-Founder and CEO at […]

Collaboration with NVIDIA and Google Cloud Provide Additional Tools and Compute Access NEW YORK — Schrödinger, Inc. (Nasdaq: SDGR) today announced the launch of its early access version of Bunsen, its new agentic AI co-scientist that helps researchers understand scientific objectives, develop computational strategies, execute sophisticated molecular discovery workflows and interpret results. By combining AI […]

Milestone Reflects Deepening Customer Centricity as DNAnexus Continues to Scale its Platform for the World’s Leading Life Sciences Organizations, Accelerating Growth By Global Expansion MOUNTAIN VIEW, Calif. — Today, DNAnexus, the world’s most trusted platform for omics data enablement, announced it has achieved a 90% customer satisfaction score (CSAT) — a milestone underscoring the trust […]

Enterprise-grade Signals software with guided onboarding positioned specifically for early-stage biotechs Science-first setup with ready-to-use Signals environments and modality-specific workflows Scalable informatics foundation that supports growth, collaboration and investor readiness WALTHAM, Mass. — Revvity, Inc. announced that its Revvity Signals Software business is launching Signals for Startups, a new program designed to help emerging biotechnology companies adopt […]